Literature DB >> 16814656

A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26.

Patrick T Ellinor1, Sabine Sasse-Klaassen, Susanne Probst, Brenda Gerull, Jordan T Shin, Andrea Toeppel, Arnd Heuser, Beate Michely, Danita M Yoerger, Bong-Seok Song, Bernhard Pilz, Gregor Krings, Bruce Coplin, Peter E Lange, G William Dec, Hans Christian Hennies, Ludwig Thierfelder, Calum A MacRae.   

Abstract

OBJECTIVES: We sought to identify the genetic locus for an inherited form of dilated cardiomyopathy (DCM) that is characterized by diffuse myocardial fibrosis and sudden death.
BACKGROUND: Genetic studies have mapped multiple loci for DCM, which is a major cause of nonischemic heart failure; however, the genes responsible for the majority of cases have yet to be identified.
METHODS: Sixty-six family members were evaluated by 12-lead electrocardiogram (ECG), echocardiogram, and laboratory studies. Individuals with echocardiographically documented DCM were defined as affected. Subjects were considered unaffected if they were older than 20 years of age, had a normal ECG and echocardiogram, no personal history of heart failure, and had no affected offspring. Genotyping was performed using polymorphic markers.
RESULTS: Genome-wide linkage analysis identified a novel locus for this inherited phenotype on chromosome 10q25.3-q26.13. Peak two-point logarithm of the odds scores >3.0 were obtained independently with each family using the markers D10S1773 and D10S1483, respectively. Haplotype analyses defined a critical interval of 14.0 centiMorgans between D10S1237 and D10S1723, corresponding to a physical distance of 9.5 megabases. Multipoint linkage analyses confirmed this interval and generated a peak logarithm of the odds score of 8.2 indicating odds of >100,000,000:1 in favor of this interval as the location of the gene defect responsible for DCM in these families.
CONCLUSIONS: We have mapped a novel locus for cardiomyopathy, diffuse myocardial fibrosis, and sudden death to chromosome 10q25-q26. The identification of the causative gene in this interval will be an important step in understanding the fundamental mechanisms of heart failure and sudden death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814656     DOI: 10.1016/j.jacc.2006.01.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.

Authors:  Marwan M Refaat; Steven A Lubitz; Seiko Makino; Zahid Islam; J Michael Frangiskakis; Haider Mehdi; Rebecca Gutmann; Michael L Zhang; Heather L Bloom; Calum A MacRae; Samuel C Dudley; Alaa A Shalaby; Raul Weiss; Dennis M McNamara; Barry London; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2011-10-17       Impact factor: 6.343

2.  Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery.

Authors:  Calum A Macrae
Journal:  Expert Opin Drug Discov       Date:  2010-07       Impact factor: 6.098

3.  A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy.

Authors:  Eric Villard; Claire Perret; Françoise Gary; Carole Proust; Gilles Dilanian; Christian Hengstenberg; Volker Ruppert; Eloisa Arbustini; Thomas Wichter; Marine Germain; Olivier Dubourg; Luigi Tavazzi; Marie-Claude Aumont; Pascal DeGroote; Laurent Fauchier; Jean-Noël Trochu; Pierre Gibelin; Jean-François Aupetit; Klaus Stark; Jeanette Erdmann; Roland Hetzer; Angharad M Roberts; Paul J R Barton; Vera Regitz-Zagrosek; Uzma Aslam; Laëtitia Duboscq-Bidot; Matthias Meyborg; Bernhard Maisch; Hugo Madeira; Anders Waldenström; Enrique Galve; John G Cleland; Richard Dorent; Gerard Roizes; Tanja Zeller; Stefan Blankenberg; Alison H Goodall; Stuart Cook; David A Tregouet; Laurence Tiret; Richard Isnard; Michel Komajda; Philippe Charron; François Cambien
Journal:  Eur Heart J       Date:  2011-04-01       Impact factor: 29.983

Review 4.  Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.

Authors:  Jonathan A Kirk; Joseph Y Cheung; Arthur M Feldman
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

Review 5.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

6.  Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice.

Authors:  Christoph D Rau; Jessica Wang; Rozeta Avetisyan; Milagros C Romay; Lisa Martin; Shuxun Ren; Yibin Wang; Aldons J Lusis
Journal:  Circ Cardiovasc Genet       Date:  2014-12-05

7.  Genome-wide association studies of coronary artery disease and heart failure: where are we going?

Authors:  Gerald W Dorn; Sharon Cresci
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

8.  Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy.

Authors:  Arthur M Feldman; Rene L Begay; Tijana Knezevic; Valerie D Myers; Dobromir B Slavov; Weizhong Zhu; Katherine Gowan; Sharon L Graw; Kenneth L Jones; Douglas G Tilley; Ryan C Coleman; Paul Walinsky; Joseph Y Cheung; Luisa Mestroni; Kamel Khalili; Mathew R G Taylor
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

9.  Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.

Authors:  Krishna G Aragam; Mark Chaffin; Rebecca T Levinson; Gregory McDermott; Seung-Hoan Choi; M Benjamin Shoemaker; Mary E Haas; Lu-Chen Weng; Mark E Lindsay; J Gustav Smith; Christopher Newton-Cheh; Dan M Roden; Barry London; Quinn S Wells; Patrick T Ellinor; Sekar Kathiresan; Steven A Lubitz
Journal:  Circulation       Date:  2018-11-11       Impact factor: 29.690

Review 10.  BAG3: a new player in the heart failure paradigm.

Authors:  Tijana Knezevic; Valerie D Myers; Jennifer Gordon; Douglas G Tilley; Thomas E Sharp; JuFang Wang; Kamel Khalili; Joseph Y Cheung; Arthur M Feldman
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.